Natarajan Sethuraman's most recent trade in Entrada Therapeutics Inc was a trade of 90,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 90,800 | 90,800 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 60,800 | 205,797 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. | 01 Mar 2025 | 6,138 | 199,659 | - | 11.7 | 71,683 | Common Stock |
| Entrada Therapeutics Inc | Sethuraman Natarajan | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.15 per share. | 29 Nov 2024 | 11,703 | 144,997 | - | 20.1 | 235,786 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.26 per share. | 29 Nov 2024 | 4,088 | 156,700 | - | 20.3 | 82,834 | Common Stock |
| Entrada Therapeutics Inc | Sethuraman Natarajan | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 29 Nov 2024 | 100 | 160,788 | - | 20 | 2,000 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 11 Nov 2024 | 2,700 | 160,888 | - | 20.0 | 54,109 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 11 Nov 2024 | 1,409 | 163,588 | - | 20.0 | 28,191 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.71 per share. | 04 Nov 2024 | 9,554 | 167,742 | - | 18.7 | 178,752 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.18 per share. | 04 Nov 2024 | 5,171 | 177,296 | - | 18.2 | 94,006 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 19.32 per share. | 04 Nov 2024 | 2,745 | 164,997 | - | 19.3 | 53,024 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.02 per share. | 04 Nov 2024 | 749 | 182,467 | - | 18.0 | 13,498 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | President, Research & Develop. | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 16 Oct 2024 | 600 | 183,216 | - | 18 | 10,800 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.09 per share. | 06 Sep 2024 | 2,642 | 183,816 | - | 15.1 | 39,862 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 06 Sep 2024 | 600 | 186,458 | - | 15.2 | 9,141 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. | 03 Sep 2024 | 955 | 187,225 | - | 15.4 | 14,729 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. | 03 Sep 2024 | 469 | 188,345 | - | 15.8 | 7,392 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 03 Sep 2024 | 167 | 187,058 | - | 15.1 | 2,526 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. | 03 Sep 2024 | 151 | 188,194 | - | 16.9 | 2,556 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. | 03 Sep 2024 | 14 | 188,180 | - | 17.7 | 248 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Jul 2024 | 638 | 188,814 | - | 18 | 11,484 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 12 Jul 2024 | 600 | 189,452 | - | 18 | 10,800 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 16 May 2024 | 9,675 | 190,052 | - | 15.2 | 146,944 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 16 May 2024 | 8,305 | 199,727 | - | 15.1 | 125,751 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 May 2024 | 1,000 | 208,032 | - | 15 | 15,000 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 66,800 | 66,800 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 44,100 | 211,298 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. | 01 Mar 2024 | 1,505 | 209,032 | - | 12.3 | 18,480 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. | 01 Mar 2024 | 414 | 210,537 | - | 13.4 | 5,534 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. | 01 Mar 2024 | 347 | 210,951 | - | 12.4 | 4,311 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 10 Jul 2023 | 14,852 | 153,447 | - | 18.0 | 267,915 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 10 Jul 2023 | 3,026 | 168,299 | - | 18.0 | 54,474 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 17 Apr 2023 | 3,961 | 171,325 | - | 18.0 | 71,316 | Common Stock |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 14,200 | 175,286 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 5,794 | 162,144 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 34,763 | 34,763 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 69,525 | 69,525 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,588 | 156,350 | - | 0 | Common Stock | |
| Entrada Therapeutics Inc | Natarajan Sethuraman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 243,639 | 243,639 | - | - | Stock Option (Right to Buy) |